Integrated Proteins Ltd
Incorporated in 1992, Integrated Proteins Ltd is in the business of trading in various oil seeds and agri commodities.[1]
- Market Cap ₹ 266 Cr.
- Current Price ₹ 14.2
- High / Low ₹ 16.3 / 2.55
- Stock P/E
- Book Value ₹ 0.63
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Stock is trading at 22.5 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.09 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.24 | 21.50 | 9.94 | |
| Sales growth | +28.57% | -11.11% | -100.00% | +41.18% | +8,858.33% | -53.77% | ||||||
| 0.14 | 0.15 | 0.09 | 0.09 | 0.14 | 0.11 | 0.10 | 0.08 | 0.26 | 0.36 | 21.40 | 9.66 | |
| Operating Profit | -0.05 | -0.07 | -0.09 | -0.09 | -0.14 | -0.11 | -0.10 | -0.08 | -0.09 | -0.12 | 0.10 | 0.28 |
| OPM % | -55.56% | -87.50% | -52.94% | -50.00% | 0.47% | 2.82% | ||||||
| 0.17 | 0.18 | 0.20 | 0.18 | 0.17 | 0.16 | 0.16 | 0.16 | 0.16 | 0.25 | 0.23 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 |
| Profit before tax | 0.09 | 0.08 | 0.08 | 0.06 | 0.00 | 0.02 | 0.03 | 0.05 | 0.04 | 0.10 | 0.32 | 0.28 |
| Tax % | 0.00% | 0.00% | 50.00% | 83.33% | 50.00% | 33.33% | 40.00% | 25.00% | 10.00% | 21.88% | 21.43% | |
| 0.09 | 0.08 | 0.05 | 0.01 | 0.02 | 0.01 | 0.02 | 0.04 | 0.03 | 0.09 | 0.25 | 0.23 | |
| EPS in Rs | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.08 | 0.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
(S): Standalone figures, shown where consolidated figures are not available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 80% |
| 3 Years: | 121% |
| 1 Year: | 271% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | |
|---|---|
| Equity Capital | 3.52 |
| Reserves | -1.20 |
| 0.00 | |
| 0.16 | |
| Total Liabilities | 2.48 |
| 0.67 | |
| CWIP | 0.00 |
| Investments | 0.01 |
| 1.80 | |
| Total Assets | 2.48 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.07 | -0.08 | -0.21 | -0.24 | 0.14 | -0.16 | -0.09 | -0.09 | -0.12 | -0.06 | -23.56 | 3.60 | |
| 0.08 | 0.18 | 0.18 | 0.18 | 0.02 | 0.03 | 0.02 | 0.01 | 0.00 | 0.34 | 2.47 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.00 | -0.09 | 0.00 | 0.03 | 0.05 | 0.11 | 0.16 | 21.12 | -3.71 | |
| Net Cash Flow | 0.01 | 0.10 | -0.02 | -0.07 | 0.08 | -0.13 | -0.03 | -0.04 | -0.01 | 0.43 | 0.03 | -0.10 |
| Free Cash Flow | -0.07 | -0.08 | -0.21 | -0.24 | 0.14 | -0.16 | -0.09 | -0.09 | -0.12 | -0.02 | -23.13 | 3.60 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 140% | 114% | 233% | 256% | -100% | 127% | 100% | 88% | 111% | 33% | -23,480% | 1,307% |
(S): Standalone figures, shown where consolidated figures are not available.
Ratios
Consolidated / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 136.88 | 0.00 | 0.00 | 0.00 | 75.64 | ||||||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 136.88 | 0.00 | 0.00 | 0.00 | 75.64 | ||||||
| Working Capital Days | -608.33 | -730.00 | -85.88 | -60.83 | 339.20 | 752.77 | ||||||
| ROCE % | 3.81% | 3.27% | 3.18% | 2.36% | 0.00% | 0.82% | 1.22% | 1.98% | 1.52% | 0.37% | 1.87% | 1.26% |
(S): Standalone figures, shown where consolidated figures are not available.
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Board Meetings Held meetings ・Standalone data |
|
||||||||
| Number of Directors on the Board directors ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Financial Result For The Quarter And Half Year Ending On 30/09/2026
-
Board Meeting Outcome for Outcome Of Boardc Meeting Held On 5Th November, 2026
- Board approved unaudited results for quarter and half year ended 30 September 2026.
-
Board Meeting Intimation for Board Meeting
- Board meets on 5 Nov 2026 to approve Q2/H1 FY2026 unaudited results; trading window opens 7 Nov.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
IPL is engaged in the business of manufacturing, trading, and processing various oilseeds. There was an operational shift in the business as:
a) The company ceased operations in the solvent extraction of oilseeds.
b) In FY24, the company explored one of its main objectives and commenced trading in agri
commodities.